Related Experiment Video
Updated: May 17, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Nonadherence in mood disorders: A formidable challenge in clinical practice
Meera Narasimhan1, Suzanne M Hardeman, Anna-Mobley Johnson
1Department of Neuropsychiatry, University of South Carolina School of Medicine, Columbia, SC, USA.
Asian Journal of Psychiatry
|October 12, 2012
Summary
Improving medication adherence in mood disorders is crucial for recovery. A personalized, evidence-based approach, including risk factor identification and patient education, enhances treatment outcomes and quality of life.
Area of Science:
- Psychiatry
- Clinical Psychology
- Patient Adherence Research
Background:
- Nonadherence to treatment is a major barrier to remission and recovery in patients with mood disorders.
- Suboptimal adherence negatively impacts patient outcomes and increases healthcare burdens.
- Effective management of mood disorders necessitates addressing nonadherence.
Purpose of the Study:
- To highlight the significance of nonadherence in mood disorders.
- To outline a comprehensive strategy for improving patient adherence.
- To emphasize the benefits of personalized, evidence-based adherence interventions.
Main Methods:
- Review of evidence-based strategies for enhancing treatment adherence.
- Identification of key risk factors contributing to nonadherence.
- Emphasis on the role of therapeutic alliances and patient/family education.
Main Results:
- Comprehensive, individualized strategies significantly improve adherence in mood disorders.
- Improved adherence leads to enhanced quality of life and reduced disease burden.
- Identifying risk factors and fostering strong therapeutic relationships are key components.
Conclusions:
- A multifaceted approach is essential for overcoming nonadherence in mood disorders.
- Personalized interventions tailored to patient needs improve treatment outcomes.
- Education and strong patient-provider relationships are vital for sustained adherence and recovery.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:19Introduction to Psychological Disorders
Abnormal behavior, often referred to as mental illness, results from changes in brain function that influence thought patterns, behaviors, and social interactions. Psychologists and psychiatrists typically assess abnormal behavior using three primary criteria: deviance, maladaptation, and personal distress, particularly when these traits persist over long periods.
Deviant Behavior
Deviance in behavior refers to actions or thought patterns that significantly diverge from societal norms or...
Deviant Behavior
Deviance in behavior refers to actions or thought patterns that significantly diverge from societal norms or...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...